CD4 and CD8 antibodies were injected 2 days prior to the injection of cancer cells, and every 5 days until the endpoint, and the efficiency of depletion was verified by FACS analysis (Supplementary Figure 1B). The gene discussed is CD8A; the disease is cancer.